Santa Cruz de Bezana adult nursing relationship

Added: Tomara Elbert - Date: 18.09.2021 12:58 - Views: 34388 - Clicks: 4717

Study record managers: refer to the Data Element Definitions if submitting registration or information. Talk with your doctor and family members or friends about deciding to a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies. Hide glossary Glossary Study record managers: refer to the Data Element Definitions if submitting registration or information. Search for terms x. Save this study.

Warning You have reached the maximum of saved studies Olaratumab LY Patient Access for Soft Tissue Sarcoma The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Last Update Posted : July 7, Study Description.

The purpose of this study is to continue to provide olaratumab to eligible patients who are currently receiving olaratumab commercially for the treatment of soft tissue sarcoma STS. Drug Information available for: Olaratumab. FDA Resources. Eligibility Criteria. Information from the National Library of Medicine Choosing to participate in a study is an important personal decision.

Inclusion Criteria: Are currently receiving olaratumab and who, in consultation with their treating physician, want to continue their course of therapy. Have metastatic or locally advanced unresectable soft tissue sarcoma not amenable to curative treatment with surgery or radiotherapy. Have given written informed consent. Females of childbearing potential and males must agree to use highly effective contraceptive precautions during treatment with olaratumab and up to 3 months following the last dose of olaratumab.

Exclusion Criteria: Breastfeeding patients who discontinue breastfeeding would be considered eligible. Contacts and Locations.

Santa Cruz de Bezana adult nursing relationship

Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials. Layout table for location contacts Contact: There may be multiple sites in this clinical trial.

More Information. National Library of Medicine U. National Institutes of Health U. Department of Health and Human Services. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators.

Soft Tissue Sarcoma. Drug: Olaratumab. Study Type :. Expanded Access Type :. Contact: There may be multiple sites in this clinical trial. Contact Principal Investigator: Elisa T Bomgaars. Principal Investigator: Barbara Galligan. Principal Investigator: Lawrence Piro. Principal Investigator: Karen W Kwan. Principal Investigator: Cannon Milani. Principal Investigator: Vishal Ranpura. Principal Investigator: Victor Villalobos. Principal Investigator: Diana Medgyesy. Principal Investigator: William Hammond.

Principal Investigator: Steven Attia. Principal Investigator: Ketan D Doshi. Principal Investigator: Yaman Suleiman.

Santa Cruz de Bezana adult nursing relationship

Principal Investigator: Thomas Samuel Sajeve. Principal Investigator: Caryn L Silver. Principal Investigator: Sumit sawhney. Contact x Principal Investigator: Ali M Sayed. Principal Investigator: James E Milner. Principal Investigator: David Bartels. Principal Investigator: Marta Batus. Principal Investigator: Vivek Sharma. Principal Investigator: Gerald Miletello. Principal Investigator: Marc R Matrana. Principal Investigator: Amin Benyounes. Principal Investigator: Stephanie Gaillard. Principal Investigator: Harvinder Singh.

Santa Cruz de Bezana adult nursing relationship

Principal Investigator: William Walsh. Clinton Township, Michigan, United States, Principal Investigator: Malathy Kilaru.

Santa Cruz de Bezana adult nursing relationship

Principal Investigator: Judy Tsai. Principal Investigator: Homam Alkaied. Principal Investigator: Domingo Musibay Evidio. Principal Investigator: Justin T Baker. Principal Investigator: Mildred Ridgway. Principal Investigator: Juan O Carden.

Santa Cruz de Bezana adult nursing relationship

Principal Investigator: Polina Khrizman. Principal Investigator: Poiesz Bernard. Principal Investigator: Seth Rahul. Greenville, North Carolina, United States, Principal Investigator: Shruti Trehan. Principal Investigator: Amanda L Jackson. Principal Investigator: Dale Shepard.

Principal Investigator: Gabriel R Tinoco. Principal Investigator: Mukhtar O Hassan. Principal Investigator: Amanda Laubenthal. Philadelphia, Pennsylvania, United States, Principal Investigator: Lee Hartner. Principal Investigator: David C Portnoy.

Principal Investigator: Michael Anthony Stipanov. Principal Investigator: Leigh Cantrell. Principal Investigator: Rachna Anand. Principal Investigator: Toni Roberts. Principal Investigator: Naixi Chen.

Santa Cruz de Bezana adult nursing relationship

Principal Investigator: Lisa Lepeak. Principal Investigator: Elizabeth Dickson. Principal Investigator: Veronika Buxhofer-Ausch. Principal Investigator: Daniela Voskova.

Santa Cruz de Bezana adult nursing relationship

Principal Investigator: Bruno Scardazzi Pozzi. Principal Investigator: Cormier Beatrice. Principal Investigator: Muhammad Khan. Principal Investigator: Muhammad Salim. Nyiregyhaza, Szabolcs-Szatmar-Bereg, Hungary, Principal Investigator: Judit Vass. Principal Investigator: Erika Hitre. Principal Investigator: Shobha Aravind.

Principal Investigator: Antonella Brunello. Policlinico S. Orsola Malpighi - Universita di Bologna. Principal Investigator: Maria Pantaleo. Principal Investigator: Carlo Messina. Principal Investigator: Jin Won Kim. Principal Investigator: Young Saing Kim. Principal Investigator: Hyojeong Kim. Principal Investigator: Joo Han Lim. Iksan-si, Jeonlabuk-do, Korea, Republic of,

Santa Cruz de Bezana adult nursing relationship

email: [email protected] - phone:(153) 541-3949 x 5780

Olaratumab (LY) Patient Access for Soft Tissue Sarcoma